Published in Int J Radiat Oncol Biol Phys on January 07, 2010
Stereotactic body radiation therapy in the re-irradiation situation--a review. Radiat Oncol (2013) 1.08
Radical irradiation of extracranial oligometastases. J Clin Oncol (2014) 1.07
Stereotactic radiation therapy for skull base recurrences: Is a salvage approach still possible? Rep Pract Oncol Radiother (2014) 0.88
Boron neutron capture therapy for advanced salivary gland carcinoma in head and neck. Int J Clin Oncol (2013) 0.88
Stereotactic radiosurgery may contribute to overall survival for patients with recurrent head and neck carcinoma. Radiat Oncol (2010) 0.88
Reirradiation of recurrent head and neck cancer using high-dose-rate brachytherapy. Acta Otorhinolaryngol Ital (2012) 0.87
Reirradiation of head and neck cancer focusing on hypofractionated stereotactic body radiation therapy. Radiat Oncol (2011) 0.87
Increasing frequency of reirradiation studies in radiation oncology: systematic review of highly cited articles. Am J Cancer Res (2013) 0.86
Clinical outcomes of single or oligo-fractionated stereotactic radiotherapy for head and neck tumors using micromultileaf collimator-based dynamic conformal arcs. J Cancer Res Clin Oncol (2012) 0.84
Survival outcomes of patients treated with hypofractionated stereotactic body radiation therapy for parotid gland tumors: a retrospective analysis. Front Oncol (2012) 0.80
Concern A retrospective, deformable registration analysis of the impact of PET-CT planning on patterns of failure in stereotactic body radiation therapy for recurrent head and neck cancer. Head Neck Oncol (2012) 0.79
Reirradiation of recurrent salivary gland malignancies with fractionated stereotactic body radiation therapy. J Radiat Oncol (2012) 0.78
Radioresistance of Brain Tumors. Cancers (Basel) (2016) 0.76
Reirradiation using robotic image-guided stereotactic radiotherapy of recurrent head and neck cancer. J Radiat Res (2016) 0.75
Stereotactic body radiotherapy for treatment of squamous cell carcinoma of the tongue associated with human papilloma virus: a case report. Front Oncol (2013) 0.75
Fractionated stereotactic radiosurgery for reirradiation of head-and-neck cancer: in regard to Unger et al. (Int J Radiat Oncol Biol Phys 2010;77:1411-1419). Int J Radiat Oncol Biol Phys (2012) 0.75
Preserving the legacy of reirradiation: A narrative review of historical publications. Adv Radiat Oncol (2017) 0.75
Role of stereotactic body radiotherapy for symptom control in head and neck cancer patients. Support Care Cancer (2014) 0.75
The role of stereotactic radiosurgery in the treatment of intramedullary spinal cord neoplasms: a systematic literature review. Neurosurg Rev (2015) 0.75
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med (2007) 10.06
Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst (2013) 8.75
Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer (2012) 3.55
Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer. J Clin Oncol (2009) 2.52
Metastatic renal cell carcinoma to the head and neck. Laryngoscope (2002) 1.95
Basal cell carcinoma chemoprevention with nonsteroidal anti-inflammatory drugs in genetically predisposed PTCH1+/- humans and mice. Cancer Prev Res (Phila) (2010) 1.91
Cancer incidence trends among Asian American populations in the United States, 1990-2008. J Natl Cancer Inst (2013) 1.90
Parathyroid carcinoma: a 43-year outcome and survival analysis. J Clin Endocrinol Metab (2011) 1.88
Phase I and pharmacokinetic study of sorafenib in patients with hepatic or renal dysfunction: CALGB 60301. J Clin Oncol (2009) 1.75
Radical stereotactic radiosurgery with real-time tumor motion tracking in the treatment of small peripheral lung tumors. Radiat Oncol (2007) 1.70
Provider knowledge and practice regarding hepatitis B screening in Chinese-speaking patients. J Cancer Educ (2007) 1.55
Healthy colon, healthy life: a novel colorectal cancer screening intervention. Am J Prev Med (2010) 1.46
Comparison of ATP-binding cassette transporter interactions with the tyrosine kinase inhibitors imatinib, nilotinib, and dasatinib. Drug Metab Dispos (2010) 1.41
CyberKnife stereotactic radiosurgical treatment of spinal tumors for pain control and quality of life. J Neurosurg Spine (2005) 1.34
A phase II study evaluating bevacizumab in combination with fixed-dose rate gemcitabine and low-dose cisplatin for metastatic pancreatic cancer: is an anti-VEGF strategy still applicable? Invest New Drugs (2008) 1.30
Reactive nitrogen species regulate autophagy through ATM-AMPK-TSC2-mediated suppression of mTORC1. Proc Natl Acad Sci U S A (2013) 1.29
Breast cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physicians. J Clin Oncol (2010) 1.27
Trends in endometrial cancer incidence by race and histology with a correction for the prevalence of hysterectomy, SEER 1992 to 2008. Cancer Epidemiol Biomarkers Prev (2012) 1.23
Use of imputed population-based cancer registry data as a method of accounting for missing information: application to estrogen receptor status for breast cancer. Am J Epidemiol (2012) 1.21
Predictors of single-gland vs multigland parathyroid disease in primary hyperparathyroidism: a simple and accurate scoring model. Arch Surg (2006) 1.20
Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors. Cancer Res (2003) 1.18
Physician preferences and attitudes regarding different models of cancer survivorship care: a comparison of primary care providers and oncologists. J Cancer Surviv (2013) 1.18
Assessing the awareness of and willingness to participate in cancer clinical trials among immigrant Latinos. J Community Health (2012) 1.16
Serum CA19-9 decline compared to radiographic response as a surrogate for clinical outcomes in patients with metastatic pancreatic cancer receiving chemotherapy. Pancreas (2008) 1.15
A phase II study of bevacizumab plus erlotinib for gemcitabine-refractory metastatic pancreatic cancer. Cancer Chemother Pharmacol (2010) 1.15
Clinical pharmacology and pharmacogenetics in a genomics era: the DMET platform. Pharmacogenomics (2010) 1.15
Cancer incidence trends among native Hawaiians and other Pacific Islanders in the United States, 1990-2008. J Natl Cancer Inst (2013) 1.14
Hypopharyngeal diverticulum formation following anterior discectomy and fusion: case series. Ear Nose Throat J (2010) 1.10
Clinical spectrum of pheochromocytoma. J Am Coll Surg (2009) 1.10
Evaluation of hypertension as a marker of bevacizumab efficacy. J Gastrointest Cancer (2009) 1.09
Healthy colon, healthy life (colon sano, vida sana): colorectal cancer screening among Latinos in Santa Clara, California. J Cancer Educ (2010) 1.08
A pilot study of intensity modulated radiation therapy with hypofractionated stereotactic body radiation therapy (SBRT) boost in the treatment of intermediate- to high-risk prostate cancer. Technol Cancer Res Treat (2010) 1.07
Expression of peripheral benzodiazepine receptor (PBR) in human tumors: relationship to breast, colorectal, and prostate tumor progression. J Recept Signal Transduct Res (2003) 1.05
Occupational injury in plastic surgeons. Plast Reconstr Surg (2010) 1.03
Clinical and molecular features of papillary thyroid cancer in adolescents and young adults. Cancer (2010) 1.02
Breast stromal enhancement on MRI is associated with response to neoadjuvant chemotherapy. AJR Am J Roentgenol (2008) 1.02
The association of intimate partner violence, recreational drug use with HIV seroprevalence among MSM. AIDS Behav (2012) 1.02
Papillary and follicular variant of papillary carcinoma of the thyroid: Initial presentation and response to therapy. Otolaryngol Head Neck Surg (2005) 1.02
Topical tazarotene chemoprevention reduces Basal cell carcinoma number and size in Ptch1+/- mice exposed to ultraviolet or ionizing radiation. Cancer Res (2004) 1.01
Treatment of chordomas with CyberKnife: georgetown university experience and treatment recommendations. Neurosurgery (2009) 0.97
A phase 1 study of efatutazone, an oral peroxisome proliferator-activated receptor gamma agonist, administered to patients with advanced malignancies. Cancer (2012) 0.95
Immunoprevention of basal cell carcinomas with recombinant hedgehog-interacting protein. J Exp Med (2004) 0.95
Comparison of the utility of covered metal stents versus uncovered metal stents in the management of malignant biliary strictures in 749 patients. Gastrointest Endosc (2013) 0.94
A phase II study of weekly docetaxel in combination with capecitabine in advanced gastric and gastroesophageal adenocarcinomas. Oncology (2010) 0.92
Safety of chronic low-dose capecitabine as maintenance therapy in gastrointestinal cancers. Gastrointest Cancer Res (2009) 0.92
Treatment of resectable gastric cancer: current standards of care. Expert Rev Anticancer Ther (2009) 0.92
Racial differences in breast cancer survival in the Detroit Metropolitan area. Breast Cancer Res Treat (2005) 0.91
Racial differences in cervical cancer survival in the Detroit metropolitan area. Cancer (2008) 0.91
CyberKnife for hilar lung tumors: report of clinical response and toxicity. J Hematol Oncol (2010) 0.91
Tumor immune profiling predicts response to anti-PD-1 therapy in human melanoma. J Clin Invest (2016) 0.89
Metabolism of isothiocyanates in individuals with positive and null GSTT1 and M1 genotypes after drinking watercress juice. Clin Nutr (2010) 0.89
A Phase I, open-label, dose escalation study of afatinib, in a 3-week-on/1-week-off schedule in patients with advanced solid tumors. Invest New Drugs (2012) 0.89
Racial differences in colorectal cancer survival in the Detroit Metropolitan Area. Cancer (2009) 0.88
Risk factors for posttreatment edema in patients treated with stereotactic radiosurgery for meningiomas. Neurosurgery (2012) 0.88
Quantification of DNA repair capacity in whole blood of patients with head and neck cancer and healthy donors by comet assay. Mutat Res (2007) 0.88
Phase II study of everolimus in patients with metastatic colorectal adenocarcinoma previously treated with bevacizumab-, fluoropyrimidine-, oxaliplatin-, and irinotecan-based regimens. Clin Cancer Res (2013) 0.87
Socioeconomic and psychosocial gradients in cardiovascular pathogen burden and immune response: the multi-ethnic study of atherosclerosis. Brain Behav Immun (2008) 0.87
How reliable is self-testing for gonorrhea and chlamydia among men who have sex with men? J Fam Pract (2013) 0.87
Physicians' beliefs about breast cancer surveillance testing are consistent with test overuse. Med Care (2013) 0.86
Patterns of cervical lymph node metastases in primary and recurrent papillary thyroid cancer. J Oncol (2011) 0.86
Does the 3-gene diagnostic assay accurately distinguish benign from malignant thyroid neoplasms? Cancer (2008) 0.86
Stress biomarkers in medical students participating in a mind body medicine skills program. Evid Based Complement Alternat Med (2011) 0.86
Treatment of malignant tumors of the skull base with multi-session radiosurgery. J Hematol Oncol (2009) 0.86
Computed tomography and otosclerosis: a practical method to correlate the sites affected to hearing loss. Ann Otol Rhinol Laryngol (2010) 0.85
Single-session and multisession CyberKnife radiosurgery for spine metastases-University of Pittsburgh and Georgetown University experience. J Neurosurg Spine (2012) 0.85
The proapoptotic molecule BLID interacts with Bcl-XL and its downregulation in breast cancer correlates with poor disease-free and overall survival. Clin Cancer Res (2010) 0.85
A population-based prospective cohort study of complications after thyroidectomy in the elderly. J Clin Endocrinol Metab (2012) 0.85
Candidate diagnostic markers and tumor suppressor genes for adrenocortical carcinoma by expression profile of genes on chromosome 11q13. World J Surg (2008) 0.84
A Bayesian approach to competing risks analysis with masked cause of death. Stat Med (2010) 0.84
Frameless fractionated stereotactic radiosurgery for vestibular schwannomas: a single-institution experience. Front Oncol (2013) 0.84
Combination antiretroviral therapy (cART) component ritonavir significantly alters docetaxel exposure. Cancer Chemother Pharmacol (2014) 0.84
First bite syndrome: a complication of surgery involving the parapharyngeal space. Head Neck (2002) 0.83
Patient and provider factors associated with colorectal cancer screening in safety net clinics serving low-income, urban immigrant Latinos. J Health Care Poor Underserved (2012) 0.83
Identifying representative trees from ensembles. Stat Med (2012) 0.83
Improving colorectal cancer screening: a partnership between primary care practices and the American Cancer Society. J Cancer Educ (2009) 0.83
4-1BB costimulation of effector T cells for adoptive immunotherapy of cancer: involvement of Bcl gene family members. J Immunother (2007) 0.83
Internet access and online cancer information seeking among Latino immigrants from safety net clinics. J Health Commun (2012) 0.83
Incidence of non-small-cell lung cancer among California Hispanics according to neighborhood socioeconomic status. J Thorac Oncol (2013) 0.82
Irreversible multitargeted ErbB family inhibitors for therapy of lung and breast cancer. Curr Cancer Drug Targets (2015) 0.82
Decreased risk of squamous cell carcinoma of the head and neck in users of nonsteroidal anti-inflammatory drugs. Int J Otolaryngol (2010) 0.82
Anti-rejection drug treatment increases basal cell carcinoma burden in Ptch1+/- mice. J Invest Dermatol (2005) 0.81
Malignant melanoma and radiotherapy: past myths, excellent local control in 146 studied lesions at Georgetown University, and improving future management. Front Oncol (2012) 0.81
A focused curriculum in surgical oncology for the third-year medical students. J Surg Res (2013) 0.81
A phase 1 study of cetuximab and lapatinib in patients with advanced solid tumor malignancies. Cancer (2015) 0.81
The impact of primary melanoma thickness and microscopic tumor burden in sentinel lymph nodes on melanoma patient survival. Ann Surg Oncol (2011) 0.80
Information channels associated with awareness of human papillomavirus infections and vaccination among Latino immigrants from safety net clinics. J Immigr Minor Health (2012) 0.80
Cetuximab in the treatment of rheumatoid arthritis. J Clin Rheumatol (2010) 0.80
Survival outcomes of patients treated with hypofractionated stereotactic body radiation therapy for parotid gland tumors: a retrospective analysis. Front Oncol (2012) 0.80
Re: "The safety and efficacy of robotic image-guided radiosurgery system treatment for intra- and extracranial lesions: a systematic review of the literature" [Radiotherapy and Oncology 89 (2009) 245-253]. Radiother Oncol (2009) 0.80
Continuum of care with anti-angiogenic therapies in metastatic colorectal cancer. J Gastrointest Oncol (2013) 0.79
Quantitation of unbound sunitinib and its metabolite N-desethyl sunitinib (SU12662) in human plasma by equilibrium dialysis and liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study. Biomed Chromatogr (2012) 0.79
Effect of multimodality treatment on overall survival for patients with metastatic or recurrent HPV-positive head and neck squamous cell carcinoma. Head Neck (2014) 0.79